Literature DB >> 12717089

Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide.

Maria M Oliva-Hemker1, David M Loeb, Susan C Abraham, Howard M Lederman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12717089     DOI： 10.1097/00005176-200305000-00010

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  5 in total

Review 1.  High-dose cyclophosphamide for autoimmunity and alloimmunity.

Authors:  Robert A Brodsky
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

2.  Autoimmune enteropathy associated with cessation of interferon-alpha therapy in chronic hepatitis C.

Authors:  German Gonzalez; Fernando P Castro; Mariana Berho; Robert Petras
Journal:  Dig Dis Sci       Date:  2009-07-29       Impact factor: 3.199

Review 3.  Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.

Authors:  Robert A Brodsky; Richard J Jones
Journal:  Autoimmunity       Date:  2008-12       Impact factor: 2.815

4.  Adult autoimmune enteropathy: Mayo Clinic Rochester experience.

Authors:  Salma Akram; Joseph A Murray; Darrell S Pardi; Glenn L Alexander; John A Schaffner; Pierre A Russo; Susan C Abraham
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-01       Impact factor: 11.382

5.  Acute Flare of Adult-Onset Autoimmune Enteropathy Associated With Cyclophosphamide.

Authors:  Jasmine Liu; Ziad Hindi; Tariq Aziz; Siwar Albashir
Journal:  ACG Case Rep J       Date:  2021-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.